Tocotrienol: A review of its therapeutic potential

被引:246
作者
Theriault, A
Chao, JT
Wang, Q
Gapor, A
Adeli, K
机构
[1] Univ Hawaii Manoa, Div Med Technol, Honolulu, HI 96822 USA
[2] Palm Oil Res Inst Malaysia, Kuala Lumpur 50720, Malaysia
[3] Hosp Sick Children, Dept Paediat Lab Med, Toronto, ON M5G 1X8, Canada
关键词
vitamin E; tocopherol; tocotrienol; cardiovascular; disease; cancer;
D O I
10.1016/S0009-9120(99)00027-2
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: To summarize new knowledge surrounding the physiological activity of tocotrienol, a natural analogue of tocopherol. Results: The biological activity of vitamin E has generally been associated with its well-defined antioxidant property, specifically against lipid peroxidation in biological membranes. In the vitamin E group, a-tocopherol is considered to be the most active form. However, recent research has suggested tocotrienol to be a better antioxidant. Moreover, tocotrienol has been shown to possess novel hypocholesterolemic effects together with an ability to reduce the atherogenic apolipoprotein B and lipoprotein(a) plasma levels. In addition, tocotrienol has been suggested to have an anti-thrombotic and anti-tumor effect indicating that tocotrienol may serve as an effective agent in the prevention and/or treatment of cardiovascular disease and cancer. Conclusion: The physiological activities of tocotrienol suggest ii to be superior than a-tocopherol in many situations. Hence, the role of tocotrienol in the prevention of cardiovascular disease and cancer may have significant clinical implications. Additional studies on its mechanism of action, as well as, long-term intervention studies, are needed to clarify its function. From the pharmacological point-of view, the current formulation of vitamin E supplements, which is comprised mainly of alpha-tocopherol, may be questionable. Copyright (C) 1999 The Canadian Society of Clinical Chemists.
引用
收藏
页码:309 / 319
页数:11
相关论文
共 98 条
[1]  
ALBERS JJ, 1989, CLIN LAB MED, V34, pB4
[2]  
Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501
[3]   THE CAUSES AND PREVENTION OF CANCER [J].
AMES, BN ;
GOLD, LS ;
WILLETT, WC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (12) :5258-5265
[4]  
AMES BN, 1999, MICROBES MALIGNANCY, P28
[5]  
[Anonymous], [No title captured]
[6]  
[Anonymous], 1992, EQUINE VET J
[7]   STRUCTURE OF THE HUMAN CYCLO-OXYGENASE-2 GENE [J].
APPLEBY, SB ;
RISTIMAKI, A ;
NEILSON, K ;
NARKO, K ;
HLA, T .
BIOCHEMICAL JOURNAL, 1994, 302 :723-727
[8]  
Bestehorn HP, 1997, EUR HEART J, V18, P226
[9]   UPDATE ON THE EFFECTS OF VITAMIN-A, VITAMIN-C, AND VITAMIN-E AND SELENIUM ON CARCINOGENESIS [J].
BIRT, DF .
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1986, 183 (03) :311-320
[10]  
BLANN AD, 1994, THROMB HAEMOSTASIS, V72, P151